USCareCheck

CMS certification 053301

UCSF Benioff Children's Hospital Oakland

747 52nd Street, Oakland, CA 94609

Childrens Emergency services

This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.

CMS overall rating Not rated Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.
Would definitely recommend No survey results published
Patient survey rating Not rated HCAHPS patient survey
Compared with the nation Too few cases for CMS to compare

What patients said

Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.

Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.

Not reported for this hospital

CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.

Clinicians registered at this address

568 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 203 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.

Specialty Clinicians
Pediatrics 206
Clinical 58
Pediatric Hematology-Oncology 19
Specialist 15
Pediatric Emergency Medicine 14
Nutrition, Pediatric 13
Anesthesiology 12
Neonatal-Perinatal Medicine 12
Psychologist 10
Dietitian, Registered 9
Pediatric Cardiology 7
Pediatric Critical Care Medicine 7

First 12 alphabetically

Money from drug and device companies

Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.

2025 total $213,589 general $6,382 · research $207,208
All years, 2019–2025 $8.5M 593 reported payments
Studies funded, 2025 12 10 companies paid in total
  • 2019 $3.2M
  • 2020 $1.4M
  • 2021 $1.8M
  • 2022 $1.3M
  • 2023 $569,949
  • 2024 $186,224
  • 2025 $213,589

General payments Research payments

What the 2025 general payments were for

Type of payment Amount Payments
Space rental and facility fees $4,000 2
Speaking, teaching and other services $1,300 1
Debt forgiveness $917 3
Royalties and licensing fees $98 1
Medical devices and supplies on long-term loan $66 1

Largest paying companies, 2025

Company Amount Payments
Abbvie INC. $172,801 10
Genetix Biotherapeutics Inc $35,566 6
Sanofi-Aventis U.S. LLC $2,000 1
New York Blood Center, Inc. $1,300 1
Haemonetics Corporation $867 1
BioMarin Pharmaceutical Inc. $840 12
Life Technologies Corporation $98 1
Teleflex LLC $66 1

Largest research studies funded here, 2025

Study Amount
A21-431;Venclexta;Blister Card: ABT-199 100mg Tablet, 1x8 Tablets ABBVIE INC. $66,637
A21-431;Venclexta;Bottle: ABT-199 100mg Yellow Film Coated Tablet 120 Tablets ABBVIE INC. $62,472
A21-431;Venclexta;Blister Card: ABT-199 100mg Film-coated Tablet 2x8, 16 Tablets ABBVIE INC. $37,483
A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent ?-Thalassemia Genetix Biotherapeutics Inc · NCT03207009 $24,220
Long-term Follow-up of Subjects With Transfusion-Dependent ?-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Genetix Biotherapeutics Inc · NCT02633943 $11,346
A21-431;Venclexta;Blister Card: ABT-199 50mg Film-coated Tablet 1x8, 8 Tablets ABBVIE INC. $2,083
A21-431;Venclexta;Blister Card: ABT-199 10mg Tablet 2x8, 16 Tablets ABBVIE INC. $2,082
A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia BioMarin Pharmaceutical Inc. $840

Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.

How to read this page

  • Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
  • “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
  • Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
  • Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
  • These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.

CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error

Common questions about UCSF Benioff Children's Hospital Oakland

Does UCSF Benioff Children's Hospital Oakland have an emergency room?

Yes. CMS lists emergency services at UCSF Benioff Children's Hospital Oakland.

Does UCSF Benioff Children's Hospital Oakland receive money from drug and device companies?

Drug and device makers reported $213,589 in payments to UCSF Benioff Children's Hospital Oakland for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.